U.S. Gas Utilities Stock News

NasdaqGS:UFCS
NasdaqGS:UFCSInsurance

United Fire Group (UFCS) Could Be 4% Overvalued Before Earnings

United Fire Group (UFCS) is approaching its August 3 earnings release, with the market expecting lower year over year earnings along with higher revenues for the June 2026 quarter. See our latest analysis for United Fire Group. At a share price of $52.76, United Fire Group has seen strong momentum build, with a 90 day share price return of 32.46% and a 1 year total shareholder return of 96.85%. This context helps frame expectations heading into earnings. If United Fire Group's recent move has...
NYSE:EXPD
NYSE:EXPDLogistics

Expeditors International Of Washington (EXPD) Pulls Back As Valuation Signals Stay Mixed

Expeditors International of Washington stock: key performance snapshot Expeditors International of Washington (EXPD) has drawn attention after recent share price moves, with the stock last closing at US$171.42. Investors are weighing this level against the company’s latest financial figures and multi year return profile. See our latest analysis for Expeditors International of Washington. Recent trading has been choppy, with a 7 day share price return that declined 4.01%. However, the 30 day...
NYSE:ENVA
NYSE:ENVAConsumer Finance

Enova International (ENVA) Lifts Outlook As Strong Results Put Valuation In Focus

Enova International (ENVA) is in focus after reporting second quarter 2026 results that topped revenue and profit expectations, raised its earnings growth outlook, and outlined Grasshopper Bank integration plans. See our latest analysis for Enova International. At a share price of $249.04, Enova International has pulled back slightly over the past day. However, a 47.73% 90 day share price return and very large 5 year total shareholder return suggest momentum has been building around its...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

Is MercadoLibre (MELI) Undervalued As Earnings Growth Meets Margin And Credit Concerns?

MercadoLibre (MELI) is back in focus after recent earnings highlighted strong revenue growth across its e-commerce and financial technology platforms, even as margins came under pressure and credit quality in Brazil drew closer investor scrutiny. See our latest analysis for MercadoLibre. MercadoLibre’s recent earnings update has come alongside a mixed price picture, with a 30 day share price return of 11.19% and a year to date share price decline of 5.63%, while the 1 year total shareholder...
NYSE:FIG
NYSE:FIGSoftware

Figma (FIG) Stock Could Be 47% Overvalued As Control Layer Hopes Grow

Figma stock has rebounded in the short term, yet after a year to date decline of 35.2% the latest valuation work still points to a premium price, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples flagging the shares as overvalued rather than clearly cheap. Year to date, Figma is down 35.2%, which means the recent rally has come off a weak base rather than from previous highs. The company is pitching itself as the control layer for modern product design,...
NYSE:GME
NYSE:GMESpecialty Retail

Will Uber Eats Partnership Redefine GameStop’s (GME) Digital Reach and Convenience Narrative?

In July 2026, Uber Technologies Inc. and GameStop Corp. announced a nationwide partnership allowing customers to order video games, consoles, accessories, collectibles, and other products from GameStop through the Uber Eats app for scheduled or on-demand delivery. This collaboration plugs GameStop’s physical store network into Uber Eats’ broad retail marketplace, aiming to meet growing demand for fast, app-based delivery of gaming and electronics products. Next, we’ll explore how GameStop’s...
NYSE:SUI
NYSE:SUIResidential REITs

Sun Communities (SUI) Stock Climbs After FFO Beat Despite Revenue Drop

Sun Communities stock came into this earnings print with a muted track record over the last quarter and a 90 day return that was slightly negative. The market shrugged that off and marked the stock up about 2.2% today. The move reflects one thing that mattered most in this release: Core funds from operations, the key profit metric for a real estate investment trust, landed at US$1.84 per share for the quarter and sat above management’s own guidance range. Is Sun Communities trading at a...
NasdaqGS:FSBC
NasdaqGS:FSBCBanks

Five Star Bancorp (FSBC) Earnings And Equity Raise Put Valuation Back In Focus

Five Star Bancorp (FSBC) just reported second quarter 2026 earnings, alongside a fresh equity raise and a recently affirmed dividend. These developments give investors several new data points to assess the regional bank stock. See our latest analysis for Five Star Bancorp. At a recent share price of $47.83, Five Star Bancorp has given investors a 34.17% year to date share price return and a 58.23% total shareholder return over the past year, even though the 7 day share price return is down...
NYSE:RTX
NYSE:RTXAerospace & Defense

Why RTX (RTX) Is Up 12.9% After Raising 2026 Outlook And Highlighting Record Backlog - And What's Next

In the past week, RTX Corporation reported second-quarter 2026 results showing revenue of US$24.71 billion and net income of US$2.14 billion, with both basic and diluted earnings per share from continuing operations rising compared with a year earlier. The company also lifted its 2026 sales and profit outlook and highlighted an expanded backlog supported by strong commercial aftermarket demand and defense orders, reinforcing revenue visibility despite ongoing supply chain and tariff-related...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Has Starbucks (SBUX) Got Too Expensive After Its 23% Rise?

Starbucks stock has gained 22.8% year to date, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples currently point to the shares trading at a premium rather than as a clear bargain. Year to date, Starbucks is up 22.8%, which raises the question of how much of the recovery story is already built into the share price. Analyst optimism around a US sales turnaround can support expectations for higher future cash flows. However, any setback in...
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (GMED) Stock Could Be Undervalued Following Q2 Earnings Date

Globus Medical stock has delivered a 49.1% return over the past year, yet its current valuation checks still lean on the cheap side, which raises the question of whether the market is fully pricing in the company’s prospects. Globus Medical is up 49.1% over the past year, which puts recent buyers sitting on sizeable gains that may already reflect improving expectations. The upcoming earnings release and investor call in early August can shape views on the company’s growth runway. At the same...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle (ORCL) Expands Ontario Health Rollout, Is The Stock Cheap Now?

Oracle (ORCL) is back in focus after Baycrest Hospital agreed to join Sunnybrook Health Sciences Centre’s Oracle Health electronic health record rollout in Ontario, extending the company’s footprint in Canadian digital health infrastructure. See our latest analysis for Oracle. For context, Oracle’s share price has fallen sharply over the past year, with a 30 day share price return down 19.24% and a year to date share price return down 38.71%, while the 1 year total shareholder return is down...
NYSE:DCOM
NYSE:DCOMBanks

Is Dime Commercial Bancshares (DCOM) Undervalued As Q2 Earnings Beat And Buybacks Return?

Dime Commercial Bancshares (DCOM) is back in focus after second quarter 2026 results exceeded revenue expectations, supported by business loan growth and disciplined deposit cost management, alongside plans to restart share repurchases in Q3. See our latest analysis for Dime Commercial Bancshares. The stronger Q2 showing comes after a period of solid momentum for Dime Commercial Bancshares, with the share price at $40.81 and a 36.63% year to date share price return, alongside a 46.80% total...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

What DLocal (DLO)'s ACI Worldwide Payments Orchestration Deal Means For Shareholders

ACI Worldwide recently announced a partnership with dLocal that plugs dLocal’s local payment network into ACI’s Payments Orchestration Platform, initially enabling global merchants to access Pix, PicPay, Mercado Pago and NuPay in Brazil, plus Mercado Pago, OXXO and SPEI in Mexico, with further rollout planned across Argentina, Chile, Colombia and Peru. By embedding dLocal’s regional payment rails into ACI’s orchestration, global merchants can use a single integration to offer preferred local...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Is Bausch + Lomb (BLCO) Undervalued As EyeGility Launch And Earnings Draw Focus?

Bausch + Lomb (BLCO) is drawing fresh attention after two linked catalysts. The company just launched its EyeGility Inserter in the U.S., and investors are watching closely ahead of this week's earnings report. See our latest analysis for Bausch + Lomb. The market reaction around the EyeGility launch and upcoming earnings has come alongside a 90-day share price return of 8.28%, while the 1-year total shareholder return of 13.38% contrasts with a 3-year total shareholder return that declined...
NasdaqGS:RKLB
NasdaqGS:RKLBAerospace & Defense

Rocket Lab (RKLB) Could Be 25% Undervalued Following Its Biggest Space Force Deal

Rocket Lab (RKLB) drew fresh attention after announcing its largest launch contract so far: a US$266 million multi launch agreement with the U.S. Space Force for at least 12 suborbital missions. See our latest analysis for Rocket Lab. Even after the contract news, Rocket Lab’s share price is down 24% over the past 30 days and 16% year to date, yet its 1 year total shareholder return is 45.9% and the 3 year total shareholder return is very large. This suggests long term momentum has been...
NYSE:AGRO
NYSE:AGROFood

Adecoagro (AGRO) Faces A Valuation Split, Is It A Bargain Or Fully Priced?

Adecoagro stock performance snapshot Adecoagro (AGRO) has seen mixed share price moves recently, with the stock down about 2% over the past day and 7% over the past week, but up roughly 7% over the past month. See our latest analysis for Adecoagro. At a share price of $10.04, Adecoagro has seen recent momentum cool, with the share price return declining 30.37% over the past 90 days, while the 1-year total shareholder return of 11.68% still reflects a positive longer-term outcome. If...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Sirius XM (SIRI) Stock Still Looks Discounted After A 54% Rally

Sirius XM Holdings stock has delivered a strong 54.5% return year to date, while the valuation checks send a more cautious message that sits somewhere between cheap and fully priced. The 54.5% gain year to date suggests sentiment around Sirius XM Holdings has shifted firmly in favour of the stock. Future expectations for subscription revenue and cash generation can support today’s price; however, any pressure on subscriber trends or pricing power may weigh on how investors value those cash...
NasdaqCM:RIOT
NasdaqCM:RIOTSoftware

Is Riot Platforms (RIOT) Undervalued Or Is Its Recent Pullback Telling A Different Story?

Riot Platforms stock response Riot Platforms (RIOT) shares closed at US$21.24 on 28 July 2026, with the stock down 3.3% on the day and 9.2% over the past week. This keeps recent volatility in focus for investors. See our latest analysis for Riot Platforms. The recent pullback in Riot Platforms’ share price, with a 1 month share price return of down 23.5% after strong gains earlier in the year, suggests momentum has cooled. However, the 1 year total shareholder return of 57.1% remains well...
NYSE:CPAY
NYSE:CPAYDiversified Financial

What Corpay (CPAY)'s New AI-Powered Agent Card Means For Shareholders

On 28 July 2026, Corpay launched Agent Card, a virtual card capability that lets AI agents create and use secure, tightly controlled payment cards for a wide range of automated business workflows. The move underscores how Corpay is embedding AI directly into payment execution, aiming to make automated procurement, travel, advertising, and supplier payments more secure and governed without sacrificing flexibility. We’ll now explore how Corpay’s new AI-ready Agent Card infrastructure could...
NYSE:HRI
NYSE:HRITrade Distributors

Herc Holdings (HRI) Stock Price Faces A 101x P E Reality Check

Herc Holdings stock just took a punch, sliding about 7% in a single session, while the latest earnings tell a far more mixed story than that one day move suggests. Q2 equipment rental revenue reached US$1.2b and net income landed at US$19m. That is a modest profit on a large revenue base, not a collapse. The real headline is the squeeze between a high trailing P/E of 101.1x and thin 1% net margins, even after reported earnings over the last year more than doubled. The market appears focused...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

CECO Environmental (CECO) Stock Could Be 37% Undervalued On Recovery Hopes

CECO Environmental stock has delivered very strong gains over the past few years, yet its recent pullback and current checks suggest the market price still sits at a discount to what an intrinsic value model implies. That mix of a big historical return and an apparent valuation gap is what investors now have to weigh. CECO Environmental has returned about 8.3x over the past 5 years, which puts recent share price weakness into the context of a very strong longer term run. Expectations for...
NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

GH Research (GHRS) Stock Looks Stretched On Its 111% YTD Run

GH Research stock has surged 111.2% year to date, yet its valuation checks indicate the shares do not screen as a clear bargain. Investors are weighing that strong run against signals that the stock may already be pricing in a lot of good news. Year to date, GH Research is up 111.2%, which puts extra focus on whether recent gains are supported by fundamentals. Optimism around GH001 after key clinical milestones and sector attention following Eli Lilly’s acquisition of Atai Life Sciences can...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk (NYSE:NVO) Stock Looks Undervalued On Cash Flow And Earnings

Novo Nordisk stock is coming off a weak patch over the past three years, yet current valuation checks and an intrinsic value estimate suggest the market price may still sit well below what its cash flows imply. The share price has declined 33.4% over the last three years, which raises the question of whether expectations have reset too far relative to the company’s fundamentals. Recent EU approval for oral and higher dose injectable Wegovy can support long term revenue and cash flow...